Pharmaniaga to focus on intensive recovery plan


Pharmaniaga said it will implement rigorous fiscal discipline initiatives across its operations and investments as part of its recovery plan.

PETALING JAYA: Pharmaniaga Bhd expects a well-executed turnaround despite the current challenges as it continues to focus on its strategic positioning and potential.

In a filing with Bursa Malaysia, the Practice Note 17-classified pharmaceutical group said it is preparing a comprehensive regulation plan to be submitted to Bursa Malaysia by the third quarter of 2023, and expects the initiative to be finalised by the first quarter of next year.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Gamuda JV secures RM1.8bil Western Sydney road project
Malaysian regulator to ask publicly-traded firms for El Nino plans, eyes deeper Middle East ties
Australian regulator sues retailer's ex-CEO for misleading market over alleged office romance
Bessent proposes US-China AI safety notifications in talks with Chinese vice premier
Australian bourse operator ASX appoints Dexus' Keir Barnes as next CFO
Tech leads shares higher in Asia, oil eases
Renewable energy stocks surge on CRESS boost
Foreign investors return to Bursa Malaysia with RM127mil net inflow
Bursa Malaysia stays subdued; renewable energy stocks buck trend
Ringgit opens mixed against major, Asean currencies after BOJ rate hike

Others Also Read